Altria Group (MO) Q3 2026 Earnings Call: Guidance and Outlook
Altria raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.66 to $5.74, reflecting a growth rate of 4.5% to 6% from a 2025 base of $5.42.
About Altria Group. Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild.
$5.66 to $5.74, representing a growth rate of 4.5% to 6% from a base of $5.42 in 2025.
Outlook
Consumer environment
Consumers remain under economic pressure due to inflation and elevated gas prices, which constrain discretionary income.
Smokeable products strategy
The company aims to maximize long-term profitability while balancing investments in Marlboro and funding smoke-free product growth.
Nicotine pouch category
Management views the category as a significant long-term harm reduction opportunity and plans to continue investing in brand equity and flavor innovation.
Regulatory environment
Management is encouraged by FDA enforcement guidance and ongoing efforts to combat illicit e-vapor products, which they believe are necessary for a level playing field.
E-vapor market
The company plans to re-enter the e-vapor market with a disciplined and profitable approach, leveraging innovation to compete effectively.
Capital allocation
The company remains committed to providing significant cash returns to shareholders, consistent with its progressive dividend goal of mid-single-digit annual growth.
Dombey's summary of the Altria Group Q3 2026 earnings call held Oct 29, 2026, written from the call itself. Every figure on this page was checked against what was said on the call, and quoted lines are management's own words; we do not add estimates or prices. The tone score is our read of management's wording, guidance and answers. Check figures against the company's SEC filings before acting. This is research, not investment advice.
